The global Capsule Endoscopy Market is entering a high-growth phase in 2025, with a current market valuation estimated at $479.13 million. Analysts project the sector will expand at a steady compound annual growth rate (CAGR) of 7.95% to 9.2%, reaching a forecasted valuation of approximately $1.37 billion by 2035. This steady climb is attributed to the increasing global incidence of gastrointestinal (GI) disorders, such as Crohn’s disease and colorectal cancer, which necessitate more frequent, patient-friendly diagnostic screenings.

The market's stability in 2025 is reinforced by the shift toward non-invasive diagnostics. Traditional endoscopy, while effective, often requires sedation and carries a higher burden of patient discomfort. In contrast, capsule endoscopy offers a "pill-sized" alternative that patients can swallow to provide a comprehensive visual of the small bowel—a region traditionally difficult to reach. The Small Bowel Capsule segment currently dominates the market, holding over 54% of the revenue share in 2025, as it remains the gold standard for detecting obscure GI bleeding (OGIB).

People Also Ask:

• What is the market value of capsule endoscopy in 2025?

• How does the CAGR for capsule endoscopy compare to traditional endoscopy?

• What are the primary diagnostic uses for capsule endoscopes?